22157.jpg
Povorcitinib (INCB054707): A Selective JAK1 Inhibitor Being Developed by Incyte Corporation - Emerging Drug Insight and Market Forecasts 2019-2022 & 2023-2032
April 13, 2023 10:28 ET | Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Povorcitinib (INCB054707) Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report...
22157.jpg
ENSPRYNG Emerging Drug Insight and Market Forecast 2023- 2032
April 10, 2023 04:03 ET | Research and Markets
Dublin, April 10, 2023 (GLOBE NEWSWIRE) -- The "ENSPRYNG Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering."ENSPRYNG Emerging Drug Insight...
22157.jpg
Sonelokimab (M1095) Research Report 2023: An Investigational ~40 kDa Humanized Nanobody - Emerging Drug Insights and Market Forecasts for 7 Major Markets 2019-2032
April 04, 2023 10:18 ET | Research and Markets
Dublin, April 04, 2023 (GLOBE NEWSWIRE) -- The "Sonelokimab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report provides...
22157.jpg
Nipocalimab Emerging Drug Insights and Market Forecasts, 2019-2022 & 2023-2032
April 04, 2023 10:13 ET | Research and Markets
Dublin, April 04, 2023 (GLOBE NEWSWIRE) -- The "Nipocalimab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report provides...
22157.jpg
Rozanolixizumab Market Research Report 2023: An SC-administered Humanized Monoclonal Antibody - Emerging Drug Insights and Forecasts 2019-2032
April 04, 2023 10:03 ET | Research and Markets
Dublin, April 04, 2023 (GLOBE NEWSWIRE) -- The "Rozanolixizumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering."Rozanolixizumab...
22157.jpg
TAVNEOS (Avacopan) for Hidradenitis Suppurativa in 7 Major Markets Report 2023: Emerging Drug Insights and Market Forecasts 2019-2032
April 04, 2023 09:58 ET | Research and Markets
Dublin, April 04, 2023 (GLOBE NEWSWIRE) -- The "TAVNEOS (Avacopan) Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report provides...
22157.jpg
BIMZELX (bimekizumab): The 1st Humanized Monoclonal IgG1 Antibody that Potently and Selectively Neutralizes Both IL-17A and IL-17F - Emerging Drug Insights and Market Forecasts 2019-2023 & 2032
March 31, 2023 07:33 ET | Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "Bimekizumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering."Bimekizumab Emerging Drug...
22157.jpg
Batoclimab: A Novel, Fully Humanized mAB for Generalized Myasthenia Gravis (gMG): Emerging Drug Insights, Sales and Market Forecasts 2019-2023 & 2032
March 31, 2023 06:43 ET | Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "Batoclimab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
UPLIZNA for Generalized Myasthenia Gravis (gMG) Emerging Drug Insights, Sales and Market Forecasts, 2019-2023 & 2024-2032
March 31, 2023 06:38 ET | Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "UPLIZNA Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
pharmather logo.png
PharmaTher Holdings Announces Update of Type C Meeting with the FDA for KETARX™ (Ketamine) in Parkinson’s Disease
March 29, 2023 07:30 ET | PharmaTher Holdings Ltd.
TORONTO, March 29, 2023 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced an update on the...